Harvard Bioscience Announces Third Quarter 2022 Financial Results
08 nov. 2022 16h01 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2022. Jim...
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET
02 nov. 2022 17h15 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2022 after the market closes on...
Harvard Bioscience Announces Second Quarter 2022 Financial Results
03 août 2022 22h48 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2022. Jim Green,...
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET
26 juil. 2022 16h50 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2022 before the market opens on...
Harvard Bioscience Announces First Quarter 2022 Financial Results
04 mai 2022 07h00 HE
|
Harvard Bioscience, Inc.
•Revenue up 7% year-over-year despite volatility in China related to COVID-19 and global supply chain headwinds HOLLISTON, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:...
Harvard Bioscience Introduces SmartStudy™: First of Kind, Next Generation Inhalation System Capability Improves Precision and Drives Growth
26 avr. 2022 09h00 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) has introduced SmartStudy™, an innovative technology feature to its Buxco® Inhalation System aimed at...
Harvard Bioscience Schedules First Quarter 2022 Earnings Conference Call for May 4, 2022 at 8:00 AM ET
21 avr. 2022 16h05 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2022 before the market opens on May...
Harvard Bioscience Announces Fourth Quarter 2021 Financial Results
08 mars 2022 07h00 HE
|
Harvard Bioscience, Inc.
Revenue up 7% year-over-year as sales momentum continues, despite global supply chain headwindsGross margin improves to 59% in Q4 driven by strengthening product mix, improved operating leverage ...
Harvard Bioscience Schedules Fourth Quarter 2021 Earnings Conference Call for March 8, 2022 at 8:00 AM ET
21 févr. 2022 16h30 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2021 before the market opens on...
Harvard Bioscience Announces Third Quarter 2021 Financial Results
03 nov. 2021 07h00 HE
|
Harvard Bioscience, Inc.
Strong double digit revenue growth, solid margin performance despite global supply chain disruptions Revenue up 23% year-over-year as sales momentum continuesPre-clinical product revenue up...